Cempra: Cempra Announces Preliminary Results of 2017 Stockholder Vote

CHAPEL HILL, N.C., Nov. 03, 2017 - Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for acute care and community settings to meet critical medical needs in the treatment of infectious diseases, today announced the preliminary results of its stockholder vote at the company's 2017 annual meeting of stockholders held today. ...This article Cempra Announces Preliminary Results of 2017 Stockholder Vote was written by DirectorsTalk Interviews.©2017 DirectorsTalk Interviews